A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2016 Jun 1

PMID 27242523

Citations 25

Authors

Isobel T French

Kalai A Muthusamy

Affiliations

Soon will be listed here.

Abstract

Sleep is an indispensable normal physiology of the human body fundamental for healthy functioning. It has been observed that Parkinson's disease (PD) not only exhibits motor symptoms, but also non-motor symptoms such as metabolic irregularities, altered olfaction, cardiovascular dysfunction, gastrointestinal complications and especially sleep disorders which is the focus of this review. A good understanding and knowledge of the different brain structures involved and how they function in the development of sleep disorders should be well comprehended in order to treat and alleviate these symptoms and enhance quality of life for PD patients. Therefore it is vital that the normal functioning of the body in relation to sleep is well understood before proceeding on to the pathophysiology of PD correlating to its symptoms. Suitable treatment can then be administered toward enhancing the quality of life of these patients, perhaps even discovering the cause for this disease.

Citing Articles

Acute sleep deprivation in mice generates protein pathology consistent with neurodegenerative diseases.

Rowe R, Schulz P, He P, Mannino G, Opp M, Sierks M Front Neurosci. 2024; 18:1436966.

PMID: 39114483 PMC: 11303328. DOI: 10.3389/fnins.2024.1436966.

Gut-Initiated Alpha Synuclein Fibrils Drive Parkinson's Disease Phenotypes: Temporal Mapping of non-Motor Symptoms and REM Sleep Behavior Disorder.

Dautan D, Paslawski W, Montejo S, Doyon D, Marangiu R, Kaplitt M bioRxiv. 2024; .

PMID: 38712208 PMC: 11071367. DOI: 10.1101/2024.04.22.590542.

Automatic sleep-wake classification and Parkinson's disease recognition using multifeature fusion with support vector machine.

Shen Y, Huai B, Wang X, Chen M, Shen X, Han M CNS Neurosci Ther. 2024; 30(4):e14708.

PMID: 38600857 PMC: 11007385. DOI: 10.1111/cns.14708.

Disrupted sleep-wake regulation in the MCI-Park mouse model of Parkinson's disease.

Summa K, Jiang P, Gonzalez-Rodriguez P, Huang X, Lin X, Vitaterna M NPJ Parkinsons Dis. 2024; 10(1):54.

PMID: 38467673 PMC: 10928107. DOI: 10.1038/s41531-024-00670-w.

Linking brain structure, cognition, and sleep: insights from clinical data.

Wei R, Ganglberger W, Sun H, Hadar P, Gollub R, Pieper S Sleep. 2023; 47(2).

PMID: 37950486 PMC: 10851868. DOI: 10.1093/sleep/zsad294.

References

Sakamoto K, Liu C, Kasamatsu M, Pozdeyev N, Iuvone P, Tosini G . Dopamine regulates melanopsin mRNA expression in intrinsically photosensitive retinal ganglion cells. Eur J Neurosci. 2005; 22(12):3129-36. DOI: 10.1111/j.1460-9568.2005.04512.x. View

Pontone G, Palanci J, Williams J, Bassett S . Screening for DSM-IV-TR cognitive disorder NOS in Parkinson's disease using the Mattis Dementia Rating Scale. Int J Geriatr Psychiatry. 2012; 28(4):364-71. PMC: 3449223. DOI: 10.1002/gps.3833. View

Llinas R, Steriade M . Bursting of thalamic neurons and states of vigilance. J Neurophysiol. 2006; 95(6):3297-308. DOI: 10.1152/jn.00166.2006. View

Langston J, FORNO L . The hypothalamus in Parkinson disease. Ann Neurol. 1978; 3(2):129-33. DOI: 10.1002/ana.410030207. View

Andretic R, Hirsh J . Circadian modulation of dopamine receptor responsiveness in Drosophila melanogaster. Proc Natl Acad Sci U S A. 2000; 97(4):1873-8. PMC: 26529. DOI: 10.1073/pnas.97.4.1873. View

Hampp G, Ripperger J, Houben T, Schmutz I, Blex C, Perreau-Lenz S . Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol. 2008; 18(9):678-83. DOI: 10.1016/j.cub.2008.04.012. View

Cole D, Kobierski L, Konradi C, Hyman S . 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc Natl Acad Sci U S A. 1994; 91(20):9631-5. PMC: 44867. DOI: 10.1073/pnas.91.20.9631. View

Holmes C, Mainville L, Jones B . Distribution of cholinergic, GABAergic and serotonergic neurons in the medial medullary reticular formation and their projections studied by cytotoxic lesions in the cat. Neuroscience. 1994; 62(4):1155-78. DOI: 10.1016/0306-4522(94)90351-4. View

Boissard R, Gervasoni D, Schmidt M, Barbagli B, Fort P, Luppi P . The rat ponto-medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study. Eur J Neurosci. 2002; 16(10):1959-73. DOI: 10.1046/j.1460-9568.2002.02257.x. View

10.

Kallio M, Haapaniemi T, Turkka J, Suominen K, Tolonen U, Sotaniemi K . Heart rate variability in patients with untreated Parkinson's disease. Eur J Neurol. 2001; 7(6):667-72. DOI: 10.1046/j.1468-1331.2000.00127.x. View

11.

Harms E, Kivimae S, Young M, Saez L . Posttranscriptional and posttranslational regulation of clock genes. J Biol Rhythms. 2004; 19(5):361-73. DOI: 10.1177/0748730404268111. View

12.

Saper C, Scammell T, Lu J . Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005; 437(7063):1257-63. DOI: 10.1038/nature04284. View

13.

Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M . The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev. 2009; 14(1):19-31. DOI: 10.1016/j.smrv.2009.04.002. View

14.

Onoue H, Yukitake M, Kurohara K, Takasima H, Kuroda Y . [A case report of Parkinson's disease presenting with recurrent dyspneic attacks due to focal laryngeal dystonia]. Rinsho Shinkeigaku. 2003; 43(4):192-4. View

15.

Nakamura T, Nakamura W, Yamazaki S, Kudo T, Cutler T, Colwell C . Age-related decline in circadian output. J Neurosci. 2011; 31(28):10201-5. PMC: 3155746. DOI: 10.1523/JNEUROSCI.0451-11.2011. View

16.

Gallopin T, Fort P, Eggermann E, Cauli B, Luppi P, Rossier J . Identification of sleep-promoting neurons in vitro. Nature. 2000; 404(6781):992-5. DOI: 10.1038/35010109. View

17.

Cermakian N, Boivin D . A molecular perspective of human circadian rhythm disorders. Brain Res Brain Res Rev. 2003; 42(3):204-20. DOI: 10.1016/s0165-0173(03)00171-1. View

18.

Cheon S, Ha M, Park M, Kim J . Nonmotor symptoms of Parkinson's disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord. 2007; 14(4):286-90. DOI: 10.1016/j.parkreldis.2007.09.002. View

19.

Sato T, Yamada R, Ukai H, Baggs J, Miraglia L, Kobayashi T . Feedback repression is required for mammalian circadian clock function. Nat Genet. 2006; 38(3):312-9. PMC: 1994933. DOI: 10.1038/ng1745. View

20.

Vazquez A, Jimenez-Jimenez F, Garcia-Ruiz P . "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy. Acta Neurol Scand. 1993; 87(1):14-8. View